Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Aug 06, 2020 12:55 pm ET
Beleave Update on Stalking Horse Sale Process
TORONTO, Aug. 6, 2020 /CNW/ - Beleave Inc. (CSE:BE) (OTC: BLEVF) ("Beleave" or the "Company") announced today that the Company, together with its affiliated entities,  Beleave Kannabis Corp., Seven Oaks Inc., 9334416 Canada Inc. O/A Medi-Green and My-Grow, Beleave Kannabis Abbotsford Inc. and Beleave Kannabis Chilliwack Inc. (collectively, the "Beleave Group"), and in consultation with Grant Thornton Limited (the "Monitor"), has completed the primary milestone within its Stalking Horse Sale Process.
Aug 06, 2020 11:12 am ET
CSE Bulletin: Suspension - Beleave Inc. (BE)
Toronto, Ontario--(Newsfile Corp. - Le 6 aout/August 2020) - Effective immediately, Beleave Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontario Securities Commission.
Aug 06, 2020 08:02 am ET
IIROC Trading Halt - BE
VANCOUVER, BC, Aug. 6, 2020 /CNW/ - The following issues have been halted by IIROC:
Jun 16, 2020 03:36 pm ET
Beleave CRO Appointment and Approval of Stalking Horse Sale Process
TORONTO, June 16, 2020 /CNW/ - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") announced today that the Company, together with its affiliated entities,  Beleave Kannabis Corp., Seven Oaks Inc., 9334416 Canada Inc. O/A Medi-Green and My-Grow, Beleave Kannabis Abbotsford Inc. and Beleave Kannabis Chilliwack Inc. (collectively, the "Beleave Group") received an order approving of a Stalking Horse Sale Process where Grant Thornton Limited (the "Monitor") will commence a process to seek offers to purchase/invest in the assets/shares of the Company.
Jun 05, 2020 04:30 pm ET
Beleave Granted Creditor Protection to Pursue Sale of Assets
TORONTO, June 5, 2020 /CNW/ - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") announced today that the Company, together with its affiliated entities,  Beleave Kannabis Corp., Seven Oaks Inc., 9334416 Canada Inc. O/A Medi-Green and My-Grow, Beleave Kannabis Abbotsford Inc. and Beleave Kannabis Chilliwack Inc. (collectively, the "Beleave Group") received an order for creditor protection (the "Initial Order") from the Ontario Superior Court of Justice (Commercial List) (the "Court") under the Companies' Creditors Arrangement Act (the "CCAA"). The Company will be making its app
Jun 05, 2020 09:47 am ET
IIROC Trade Resumption - BE
VANCOUVER, BC, June 5, 2020 /CNW/ - Trading resumes in:
Jun 05, 2020 09:11 am ET
Beleave To Seek Creditor Protection to Pursue Sale of Assets
TORONTO, June 5, 2020 /CNW/ - Beleave Inc. (CSE:BE) (OTC: BLEVF) ("Beleave" or the "Company") announced today that the Company, together with its affiliated entities,  Beleave Kannabis Corp., Seven Oaks Inc., 9334416 Canada Inc. O/A Medi-Green and My-Grow, Beleave Kannabis Abbotsford Inc. and Beleave Kannabis Chilliwack Inc. (collectively, the "Beleave Group") has received the approval of its directors to make application for an order for creditor protection (the "Initial Order") from the Ontario Superior Court of Justice (Commercial List) (the "Court") under the Companies' Creditors Arrange
Jun 05, 2020 08:06 am ET
IIROC Trading Halt - BE
VANCOUVER, BC, June 5, 2020 /CNW/ - The following issues have been halted by IIROC:
May 04, 2020 04:44 pm ET
CSE Bulletin: Reinstatement - Beleave Inc. (BE)
Toronto, Ontario--(Newsfile Corp. - Le 4 mai/May 2020) - Effective immediately Beleave Inc. will be reinstated for trading.
May 04, 2020 11:33 am ET
IIROC Trade Resumption - BE
VANCOUVER, May 4, 2020 /CNW/ - Trading resumes in:
Apr 29, 2020 11:04 am ET
Beleave Refiles Amended and Restated MD&A and Financial Statements
Toronto, Ontario--(Newsfile Corp. - April 29, 2020) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, today announced the refiling of amended and restated unaudited condensed consolidated interim financial statements (the "Q3 2020 FS") and management's discussion and analysis thereof ("Q3 2020 MD&A", together with the Q3 2020 FS, the "Amended Statements"). The revisions to the Amended Statements have been made at the request of OSC staff in connection with a continuous disclosure review.
Apr 20, 2020 01:38 pm ET
CSE Bulletin: Suspension - Beleave Inc. (BE)
Toronto, Ontario--(Newsfile Corp. - le 20 avril/April 2020) - Effective immediately Beleave Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. Cease trade orders have been issued by the Ontario Securities Commission.
Apr 20, 2020 08:22 am ET
Beleave Files Amended and Restated Financial Statements
Toronto, Ontario--(Newsfile Corp. - April 20, 2020) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, today announced the filing of amended and restated management's discussion and analysis and amended and restated unaudited condensed consolidated interim financial statements.
Apr 20, 2020 08:14 am ET
IIROC Trading Halt - BE
VANCOUVER, April 20, 2020 /CNW/ - The following issues have been halted by IIROC:
Apr 17, 2020 02:55 pm ET
Beleave's Q3 Financials Should Not Be Relied Upon
Toronto, Ontario--(Newsfile Corp. - April 17, 2020) - Beleave Inc. (CSE: BE) (OTC Pink: BLEVF) ("Beleave" or the "Company") announces that the previously filed unaudited interim financial statements for the three and nine months ended December 31, 2019 (the "Q3 Financials") were incomplete and missing a statement of changes in equity and notes to such financial statements and therefore should no longer be relied upon.
Apr 17, 2020 02:33 pm ET
IIROC Trading Halt - BE
VANCOUVER, April 17, 2020 /CNW/ - The following issues have been halted by IIROC:
Apr 13, 2020 08:34 am ET
Beleave Provides Operational and Leadership Updates
Toronto, Ontario--(Newsfile Corp. - April 13, 2020) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, provides an update on internal operations and leadership changes at the Company.
Mar 03, 2020 12:18 pm ET
Beleave Enters LOI with Dutchman's Gold to Partner on Cannabis Infused Honey Products
Toronto, Ontario--(Newsfile Corp. - March 3, 2020) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, announces that it has entered into a non-binding Letter of Intent ("LOI") with Dutchman's Gold, on March 2, 2020, to partner on the production and distribution of cannabis-infused natural honey and maple syrup products under the Sticky Icky and Dutchman's Gold brands for the Cannabis 2.0 Canadian market.
Mar 02, 2020 05:05 pm ET
Beleave Announces Approval for Sales in Alberta
Toronto, Ontario--(Newsfile Corp. - March 2, 2020) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, announces that it is now approved for sales in the province of Alberta.
Feb 26, 2020 08:49 am ET
Beleave Expands Cannabis 2.0 Product Roll Out to British Columbia with Flyte Classic Vaporizer
Toronto, Ontario--(Newsfile Corp. - February 26, 2020) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company"), a licensed producer of cannabis and cannabis-derived products, continues the roll out of its portfolio of adult use cannabis products with Flyte Classic vape pens, recently relaunched into the Canadian market in conjunction with Volero Brands Inc. ("Volero"). The product is now available in the brand's home province, British Columbia, with Manitoba and Saskatchewan product deliveries this week.
Jan 24, 2020 09:22 am ET
Beleave Announces Consulting Agreement with Shaxon Enterprises
Toronto, Ontario--(Newsfile Corp. - January 24, 2020) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has entered into a consulting agreement (the "Agreement") with Shaxon Enterprises Ltd. ("Shaxon" or the "Consultant"), with respect to Shaxon providing consulting services to the Company, effective February 1, 2020.
Dec 19, 2019 09:25 am ET
Beleave Receives Purchase Order for Cannabis 2.0 Products and Provides Other Operational Updates
Announcing new product line, Compliance Brand, to join Flyte Classic vape pens in Cannabis 2.0 product line, The Company has $2.7 Million in orders for Cannabis 2.0 products, which will ship in early 2020
Dec 19, 2019 08:40 am ET
Beleave Provides Update on Company Leadership
Toronto, Ontario--(Newsfile Corp. - December 19, 2019) - Today, Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") announces the appointment of Mr. Kevin Keagan as its Chief Executive Officer, effective immediately, replacing Ms. Jeannette VanderMarel, who has resigned from her position. Ms. VanderMarel will maintain her position on the Company's board.
Dec 19, 2019 08:37 am ET
IIROC Trade Resumption - BE
VANCOUVER, Dec. 19, 2019 /CNW/ - Trading resumes in:
Dec 18, 2019 12:57 pm ET
IIROC Trading Halt - BE
VANCOUVER, Dec. 18, 2019 /CNW/ - The following issues have been halted by IIROC:
Dec 03, 2019 05:00 pm ET
Beleave Announces Election of Board of Directors and AGM 2019 Summary
Toronto, Ontario--(Newsfile Corp. - December 3, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") today announced the results from its Annual General Meeting of Shareholders (the "Meeting" or "AGM"), held in Toronto, Ontario, on December 2, 2019. The Meeting was chaired by Beleave's CEO, Jeannette VanderMarel.
Nov 29, 2019 05:16 pm ET
Beleave Announces AGM Conference Call Details
Toronto, Ontario--(Newsfile Corp. - November 29, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") is pleased to announce that it will hold its Annual General Meeting ("AGM" or "Meeting") on December 2, 2019 in Toronto, Ontario.
Oct 31, 2019 09:07 am ET
Beleave Announces Joint Venture with Volero Brands to Launch Cannabis 2.0 Products in Canada
Toronto, Ontario--(Newsfile Corp. - October 31, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") and Volero Brands Inc. ("Volero") are pleased to announce that they have entered into a definitive agreement (the "Joint Venture Agreement") to form a joint venture (the "Joint Venture" or "Partnership") to develop, produce, and distribute cannabis extracts, topicals and edibles for the Canadian market.
Oct 30, 2019 05:12 pm ET
Beleave Receives License to Sell Cannabis Extracts, Topicals and Edibles
Toronto, Ontario--(Newsfile Corp. - October 30, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary Beleave Kannabis Corp. has received an amendment to its processing license from Health Canada for its ISO certified facility in Hamilton, Ontario to authorize the sale of cannabis extracts, topicals and edible products to provincially and territorially authorized retailers and holders of a license for sale for medical purposes.
Oct 30, 2019 08:55 am ET
Beleave Announces Date of 2019 Annual General Meeting
Toronto, Ontario--(Newsfile Corp. - October 30, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") is pleased to announce that it will hold its Annual General Meeting ("AGM" or "Meeting") on December 2, 2019 in Toronto, Ontario.
Oct 29, 2019 05:56 pm ET
Beleave Appoints Jeannette VanderMarel to Board of Directors
Toronto, Ontario--(Newsfile Corp. - October 29, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") is pleased to announce updates to its Board of Directors (the "Board"), taking effect today. The Company has elected newly appointed Beleave CEO Jeannette VanderMarel to the Board.
Oct 28, 2019 08:26 am ET
Beleave Appoints Jeannette VanderMarel Chief Executive Officer
Toronto, Ontario--(Newsfile Corp. - October 28, 2019) - Beleave's (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") Board of Directors announced that Jeannette VanderMarel has been appointed the Company's Chief Executive Officer. Bill Panagiotakopoulos, who took over as CEO earlier this year, will return to his role as Beleave's COO. These changes are effective today.
Sep 20, 2019 05:16 pm ET
Beleave Provides Bi-Weekly Default Status Update
Toronto, Ontario--(Newsfile Corp. - September 20, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") provides a status update on the management cease trade order (the "MCTO") which was granted by the Ontario Securities Commission (the "OSC") last month and the release of its Q1 2019 financials.
Sep 19, 2019 08:53 am ET
Sep 06, 2019 05:00 pm ET
Beleave Provides Bi-Weekly Default Status Update
Toronto, Ontario--(Newsfile Corp. - September 6, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") provides a status update on the management cease trade order (the "MCTO") which was granted by the Ontario Securities Commission (the "OSC") last month and the release of its Q1 2019 financials.
Aug 29, 2019 08:43 am ET
Beleave Announces LOI for Leaseback of London Production Facility and Sale of Lloydminster Retail Space
Toronto, Ontario--(Newsfile Corp. - August 29, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce the signing of a letter of intent (the "LOI") on Tuesday, August 27, 2019, to negotiate, in good faith, with a private purchaser (the "Purchaser") to sell the Company's London, Ontario cultivation facility. Beleave will lease back 50 percent of the property after the sale is finalized to continue using the facility for cannabis production. Beleave is also announcing the sale of its Saskatchewan retail store in Lloydminster.
Aug 23, 2019 05:00 pm ET
Beleave Provides Bi-Weekly Default Status Report
Toronto, Ontario--(Newsfile Corp. - August 23, 2019) -  Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") hereby provides a status report on the management cease trade order ("MCTO"), announced in the Company's news release from August 8, 2019 (the "Default Announcement"), which was granted by the Ontario Securities Commission (the "OSC"), its principal regulator.
Aug 13, 2019 07:30 am ET
Beleave's New Research License Allows for Further Optimization of Cannabinoids for Capsules and Edibles
Toronto, Ontario--(Newsfile Corp. - August 13, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that on Friday, August 9, 2019, the Company's wholly-owned subsidiary Beleave Kannabis Corp was issued a Research License ("License") under the Cannabis Act and Cannabis Regulations of Canada. All research conducted under this License will be based on research protocols involving the further optimization and validation of methods for formulating cannabinoid compounds for oral ingestion.
Aug 09, 2019 07:35 am ET
Beleave Announces Sale of Popular Blue Dream Strain
Toronto, Ontario--(Newsfile Corp. - August 9, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that on July 31, 2019 the company commenced the sale of its Blue Dream strain to medical patients under the Beleave Kannabis Corp. medicinal brand.
Aug 08, 2019 05:00 pm ET
Beleave Granted Management Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - August 8, 2019) - Beleave Inc. (CSE: BE) (OTC: BLEVF) ("Beleave" or the "Company") announces that its principal regulator, the Ontario Securities Commission, has accepted the Company's application for, and has granted, a management cease trade order ("MCTO").
Aug 08, 2019 10:23 am ET
IIROC Trade Resumption - BE
VANCOUVER, Aug. 8, 2019 /CNW/ - Trading resumes in:
Aug 07, 2019 03:47 pm ET
Beleave Announces Non-Binding LOI with TerraFarma Inc.
Toronto, Ontario--(Newsfile Corp. - August 7, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that the Company has entered into a non-binding letter of intent (the "LOI") that contemplates a business combination with TerraFarma Inc. ("TerraFarma").
Jul 30, 2019 01:00 pm ET
Beleave Announces Delay in Filing of Audited Financials
TORONTO, July 30, 2019 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces that it expects to file its audited annual financial statements and management's discussion and analysis for the twelve months ended March 31, 2019, which were required to be filed by July 29, 2019, in the next thirty days.
Jul 30, 2019 01:00 pm ET
Beleave Announces Delay in Filing of Audited Financials
TORONTO, July 30, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces that it expects to file its audited annual financial statements and management's discussion and analysis for the twelve months ended March 31, 2019, which were required to be filed by July 29, 2019, in the next thirty days.
Jul 30, 2019 11:57 am ET
IIROC Trading Halt - BE
VANCOUVER, July 30, 2019  /CNW/ - The following issues have been halted by IIROC:
Jul 11, 2019 08:24 am ET
Beleave Commences Sales of Cannabis Oils for the Canadian Adult Use Market
First order shipped to Saskatchewan; purchase orders for other provinces and retailers imminent.
Jun 28, 2019 04:30 pm ET
Beleave Releases Restated Financials with 7% Revenue Increase for the Nine Months Ended December 31, 2018
Toronto, Ontario--(Newsfile Corp. - June 28, 2019) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces today the release of its restated Condensed Interim Consolidated Financial Statements for three and nine months ended December 31, 2018, together with its Management, Discussion and Analysis ("MD&A").
Jun 27, 2019 08:18 am ET
Beleave Expands Recreational Cannabis Sales to Saskatchewan
First Recreational Cannabis Shipment to Saskatchewan Marks Beleave's Expansion to Fourth Canadian Province
Jun 24, 2019 01:29 pm ET
IIROC Trade Resumption - BE
VANCOUVER, June 24, 2019 /CNW/ - Trading resumes in:
Jun 24, 2019 01:16 pm ET
Beleave Receives Green Light for Building Permit as Hamilton Phase 2 Expansion Moves Forward
Beleave will add almost 100,000 sq. ft.for cannabis extraction, processing, and cultivation. Phase 2 expects to generate approximately $50 million in annualized revenue with an average gross profit margin of 60 percent once fully operational.
Jun 24, 2019 09:11 am ET
IIROC Trading Halt - BE
VANCOUVER, June 24, 2019 /CNW/ - The following issues have been halted by IIROC:
Jun 07, 2019 09:32 am ET
IIROC Trade Resumption - BE
VANCOUVER, June 7, 2019 /CNW/ - Trading resumes in:
Jun 06, 2019 08:41 am ET
IIROC Trading Halt - BE
VANCOUVER, June 6, 2019 /CNW/ - The following issues have been halted by IIROC:
Jun 06, 2019 07:54 am ET
Beleave Updates Prior Disclosure and Announces Approval of Settlement Agreement with the BCSC
TORONTO, June 6, 2019 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) today announces a settlement with the British Columbia Securities Commission ("BCSC"), and provides updates to certain prior disclosure regarding agreements entered into and shares issued by the Company during its fiscal year ended March 31, 2019. All values in this news release are in Canadian dollars.
Jun 05, 2019 02:40 pm ET
IIROC Trading Halt - BE
VANCOUVER, June 5, 2019 /CNW/ - The following issues have been halted by IIROC:
May 30, 2019 07:31 am ET
Beleave Expands Product Line with New Beleave-Branded Product Shipped to the OCS
Beleave's San Fernando Valley marks the first Beleave-branded product marketed to the recreational market.
May 23, 2019 08:12 am ET
Beleave Receives Approval for Hamilton Facility Expansion from City Council
Beleave will add roughly 100,000 sq. ft. for cannabis extraction, processing, and cultivation.
May 15, 2019 08:36 am ET
Beleave Receives Unanimous Approval from Hamilton Planning Committee
TORONTO, May 15, 2019 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its meeting with the Hamilton Planning Committee on May 14, 2019.
May 15, 2019 08:36 am ET
Beleave Receives Unanimous Approval from Hamilton Planning Committee
TORONTO, May 15, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its meeting with the Hamilton Planning Committee on May 14, 2019.
May 07, 2019 09:08 am ET
Beleave's Hamilton Expansion Set for Consideration by Planning Committee on May 14
Beleave to add roughly 100,000 sq ft to Cannabis Growing and Harvesting Facility
May 07, 2019 09:08 am ET
Beleave's Hamilton Expansion Set for Consideration by Planning Committee on May 14
Beleave to add roughly 100,000 sq ft to Cannabis Growing and Harvesting Facility
Apr 08, 2019 07:30 am ET
Beleave Announces Initial Cannabis Oil Sales After Receiving Health Canada Authorization
Derivatives with Higher-Margins Increasing Growth and Revenues
Apr 08, 2019 07:30 am ET
Beleave Announces Initial Cannabis Oil Sales After Receiving Health Canada Authorization
Derivatives with Higher-Margins Increasing Growth and Revenues
Apr 05, 2019 09:14 am ET
Beleave Granted Building Permit for Upcoming London Expansion
TORONTO, April 5, 2019 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has received a Building Permit and moved forward in the Health Canada Licensing process for its facility in London, Ontario.
Apr 05, 2019 09:14 am ET
Beleave Granted Building Permit for Upcoming London Expansion
TORONTO, April 5, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has received a Building Permit and moved forward in the Health Canada Licensing process for its facility in London, Ontario.
Mar 04, 2019 07:57 am ET
Beleave Announces 256% Increase in Revenues in Third Quarter of 2018 Results
TORONTO, March 4, 2019 /CNW/ - Beleave (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces that it released the Company's Interim Condensed Consolidated Financial Statements for the third quarter for the three and nine months ended December 31, 2018, together with its Management, Discussion and Analysis ("MD&A") on March 1, 2019. These documents were posted on the Company's website at www.beleave.com and SEDAR at www.sedar.com. All amounts in this news release and the Company's financial disclosures are in Canadian dollars, except per share amounts or as indicated otherwise.
Mar 04, 2019 07:57 am ET
Beleave Announces 256% Increase in Revenues in Third Quarter of 2018 Results
TORONTO, March 4, 2019 /PRNewswire/ - Beleave (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces that it released the Company's Interim Condensed Consolidated Financial Statements for the third quarter for the three and nine months ended December 31, 2018, together with its Management, Discussion and Analysis ("MD&A") on March 1, 2019. These documents were posted on the Company's website at www.beleave.com and SEDAR at www.sedar.com. All amounts in this news release and the Company's financial disclosures are in Canadian dollars, except per share amounts or as indicated othe
Mar 01, 2019 07:59 am ET
Beleave's New Board Makes Key Appointments to Strengthen Independence
TORONTO, March 1, 2019 /CNW/ - Beleave (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to welcome Amy Nederlander as a new Independent Director and to announce the appointment of an Independent Chairman of its Board.
Mar 01, 2019 07:59 am ET
Beleave's New Board Makes Key Appointments to Strengthen Independence
TORONTO, March 1, 2019 /PRNewswire/ - Beleave (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to welcome Amy Nederlander as a new Independent Director and to announce the appointment of an Independent Chairman of its Board.
Feb 19, 2019 07:49 am ET
Beleave Announces Board and Management Refresh
TORONTO, Feb. 19, 2019 /CNW/ - Beleave (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce a refresh of its Board of Directors with the appointment of three new Independent Directors and one Inside Director to enhance the Company's focus on governance, and emerging and capital markets.  The newly appointed Independent Directors are:
Feb 19, 2019 07:49 am ET
Beleave Announces Board and Management Refresh
TORONTO, Feb. 19, 2019 /PRNewswire/ - Beleave (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce a refresh of its Board of Directors with the appointment of three new Independent Directors and one Inside Director to enhance the Company's focus on governance, and emerging and capital markets.  The newly appointed Independent Directors are:
Feb 12, 2019 07:38 am ET
Medi-Green Invites the Community to Grand Opening of its New Clinic in London, Ontario
TORONTO, Feb. 12, 2019 /CNW/ - Medi-Green, a wholly-owned subsidiary of Beleave (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to invite the community to the grand opening event of its new clinic in London, Ontario this Friday, February 15, 2019.
Feb 12, 2019 07:38 am ET
Medi-Green Invites the Community to Grand Opening of its New Clinic in London, Ontario
TORONTO, Feb. 12, 2019 /PRNewswire/ - Medi-Green, a wholly-owned subsidiary of Beleave (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to invite the community to the grand opening event of its new clinic in London, Ontario this Friday, February 15, 2019.
Jan 31, 2019 07:42 am ET
Beleave Awarded ISO 9001:2015 Certification as Part of Ongoing Commitment to Improve Efficiency
TORONTO, Jan. 31, 2019 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corporation, has obtained ISO 9001:2015 Certification for the research, development, and production of cannabis products for medicinal and recreational purposes at its Hamilton, Ontario facility.
Jan 31, 2019 07:42 am ET
Beleave Awarded ISO 9001:2015 Certification as Part of Ongoing Commitment to Improve Efficiency
TORONTO, Jan. 31, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corporation, has obtained ISO 9001:2015 Certification for the research, development, and production of cannabis products for medicinal and recreational purposes at its Hamilton, Ontario facility.
Jan 17, 2019 07:29 am ET
Beleave Provides an Update on the BCSC's Temporary Order
TORONTO, Jan. 17, 2019 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its participation and cooperation regarding the ongoing investigation by the British Colombia Securities Commission ("BCSC").
Jan 17, 2019 07:29 am ET
Beleave Provides an Update on the BCSC's Temporary Order
TORONTO, Jan. 17, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to provide an update on its participation and cooperation regarding the ongoing investigation by the British Colombia Securities Commission ("BCSC").
Jan 16, 2019 07:40 am ET
Beleave Announces Executive Management Developments and Provides Activity Updates
TORONTO, Jan. 16, 2019 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces that Bill Panagiotakopoulos, current COO at Beleave, has been appointed by the Board of Directors to act as the Executive Chairman to further strengthen Beleave's governance and oversight controls.
Jan 16, 2019 07:40 am ET
Beleave Announces Executive Management Developments and Provides Activity Updates
TORONTO, Jan. 16, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces that Bill Panagiotakopoulos, current COO at Beleave, has been appointed by the Board of Directors to act as the Executive Chairman to further strengthen Beleave's governance and oversight controls.
Jan 15, 2019 07:19 am ET
Beleave Receives Health Canada Authorization to Sell Cannabis Oils
TORONTO, Jan. 15, 2019 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce its wholly-owned subsidiary Beleave Kannabis Corp. has been authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended licence with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations.
Jan 15, 2019 07:19 am ET
Beleave Receives Health Canada Authorization to Sell Cannabis Oils
TORONTO, Jan. 15, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce its wholly-owned subsidiary Beleave Kannabis Corp. has been authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended licence with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations.
Dec 17, 2018 04:54 pm ET
Beleave Provides Update and Clarification on GMP Certification Process
TORONTO, Dec. 17, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to provide an update and clarification on the Company's GMP certification process.
Dec 17, 2018 04:54 pm ET
Beleave Provides Update and Clarification on GMP Certification Process
TORONTO, Dec. 17, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to provide an update and clarification on the Company's GMP certification process.
Dec 13, 2018 09:51 pm ET
CORRECTION - Beleave Announces GMP Certification and Operational Updates
Please note that the below is a corrected version of the news release previously disseminated December 13th at 5pm. Beleave Inc. has advised that changes were made to the third and fourth paragraphs.
Dec 13, 2018 09:51 pm ET
CORRECTION - Beleave Announces GMP Certification and Operational Updates
Please note that the below is a corrected version of the news release previously disseminated December 13th at 5pm. Beleave Inc. has advised that changes were made to the third and fourth paragraphs.
Dec 13, 2018 04:00 pm ET
Beleave Announces GMP Certification and Operational Updates
TORONTO, Dec. 13, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification.
Dec 13, 2018 04:00 pm ET
Beleave Announces GMP Certification and Operational Updates
TORONTO, Dec. 13, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification.
Nov 29, 2018 04:44 pm ET
Beleave Announces Second Quarter of 2018 Results
51% increase in revenues from Q1with 250% increase forecasted for Q3Strong Revenue Growth Expected for rest of Fiscal 2018
Nov 29, 2018 04:44 pm ET
Beleave Announces Second Quarter of 2018 Results
51% increase in revenues from Q1with 250% increase forecasted for Q3Strong Revenue Growth Expected for rest of Fiscal 2018
Nov 27, 2018 06:00 am ET
/R E P E A T -- Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call/
Second Quarter 2018 Results will be Released After Market on Thursday, November 29, 2018, Followed by the Company's First Ever Conference Call on Friday, November 30, 2018 at 11:00 A.M. EDT
Nov 27, 2018 06:00 am ET
/R E P E A T -- Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call/
Second Quarter 2018 Results will be Released After Market on Thursday, November 29, 2018, Followed by the Company's First Ever Conference Call on Friday, November 30, 2018 at 11:00 A.M. EDT
Nov 23, 2018 02:25 pm ET
Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call
Second Quarter 2018 Results will be Released After Market on Thursday, November 29, 2018, Followed by the Company's First Ever Conference Call on Friday, November 30, 2018 at 11:00 A.M. EDT
Nov 23, 2018 02:25 pm ET
Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call
Second Quarter 2018 Results will be Released After Market on Thursday, November 29, 2018, Followed by the Company's First Ever Conference Call on Friday, November 30, 2018 at 11:00 A.M. EDT
Nov 15, 2018 07:38 am ET
Beleave Announces Development of Cannabis-Infused Powder and Sugar Products for the Recreational Market
TORONTO, Nov. 15, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market next year.
Nov 15, 2018 07:38 am ET
Beleave Announces Development of Cannabis-Infused Powder and Sugar Products for the Recreational Market
TORONTO, Nov. 15, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market next year.
Nov 12, 2018 07:33 am ET
Beleave Introduces 90 New Cannabis Varieties as it Secures Genetics Acquisition Agreements
TORONTO, Nov. 12, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has secured genetics acquisition agreements for a broad range of cannabis seed varieties from diverse lineages.
Nov 12, 2018 07:33 am ET
Beleave Introduces 90 New Cannabis Varieties as it Secures Genetics Acquisition Agreements
TORONTO, Nov. 12, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has secured genetics acquisition agreements for a broad range of cannabis seed varieties from diverse lineages.
Nov 09, 2018 07:52 am ET
Beleave Announces Strategic Alliance Agreement with Rollins Group to Open and Operate Cannabis Retail Stores Across Canada
TORONTO, Nov. 9, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has entered into a Strategic Alliance Agreement (the "Agreement") with the Rollins Group Inc. ("Rollins") to open and operate cannabis retail stores across Canada.
Nov 09, 2018 07:52 am ET
Beleave Announces Strategic Alliance Agreement with Rollins Group to Open and Operate Cannabis Retail Stores Across Canada
TORONTO, Nov. 9, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has entered into a Strategic Alliance Agreement (the "Agreement") with the Rollins Group Inc. ("Rollins") to open and operate cannabis retail stores across Canada.
Nov 05, 2018 06:00 am ET
Beleave Announces Seven-for-One Share Split
TORONTO, Nov. 5, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce a seven-for-one share split of the Company's issued and outstanding common shares (the "Share Split"). Each shareholder of record of the Company as of the close of business on the Record Date will receive six additional shares for each share held on such date.
Nov 05, 2018 06:00 am ET
Beleave Announces Seven-for-One Share Split
TORONTO, Nov. 5, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce a seven-for-one share split of the Company's issued and outstanding common shares (the "Share Split"). Each shareholder of record of the Company as of the close of business on the Record Date will receive six additional shares for each share held on such date.
Oct 29, 2018 08:39 am ET
Beleave Penetrates European Cannabis Market through Strategic Partnership and Adds VP International Sales
TORONTO, Oct. 29, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has signed an agreement with Canymed GmbH ("Canymed") to supply the German market with medical cannabis. This move is the first of a series of strategic initiatives to penetrate the robust European cannabis market and marks the Company's expansion into its third continent alongside both North and South America.
Oct 29, 2018 08:39 am ET
Beleave Penetrates European Cannabis Market through Strategic Partnership and Adds VP International Sales
TORONTO, Oct. 29, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has signed an agreement with Canymed GmbH ("Canymed") to supply the German market with medical cannabis. This move is the first of a series of strategic initiatives to penetrate the robust European cannabis market and marks the Company's expansion into its third continent alongside both North and South America.
Oct 24, 2018 08:49 am ET
Kevin Keagan Joins Beleave as Chief Communications Officer
TORONTO, Oct. 24, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that Kevin Keagan has joined the Company as Chief Communications Officer, and a member of the Executive Team.
Oct 24, 2018 08:49 am ET
Kevin Keagan Joins Beleave as Chief Communications Officer
TORONTO, Oct. 24, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that Kevin Keagan has joined the Company as Chief Communications Officer, and a member of the Executive Team.
Oct 17, 2018 08:32 am ET
Beleave's Statement on Historic Day for Cannabis in Canada
TORONTO, Oct. 17, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") would like to recognize the steadfastness, bravery, and leadership of the Canadian government, as well as other pioneers in the community who have worked tirelessly for years, to bring this day to pass.
Oct 17, 2018 08:32 am ET
Beleave's Statement on Historic Day for Cannabis in Canada
TORONTO, Oct. 17, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") would like to recognize the steadfastness, bravery, and leadership of the Canadian government, as well as other pioneers in the community who have worked tirelessly for years, to bring this day to pass.
Oct 01, 2018 09:13 am ET
Beleave Provides Update on B.C. Indoor Facilities
TORONTO, Oct 1, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it is has filed an application with Health Canada and, once approved, is ready to proceed with phase one in Chilliwack of the its recently-announced indoor cultivation cannabis project in British Columbia.
Oct 01, 2018 09:13 am ET
Beleave Provides Update on B.C. Indoor Facilities
TORONTO, Oct 1, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it is has filed an application with Health Canada and, once approved, is ready to proceed with phase one in Chilliwack of the its recently-announced indoor cultivation cannabis project in British Columbia.
Sep 26, 2018 08:41 am ET
Beleave Announces Increased Investment Agreement with Alumina Partners and Executive Management Update
TORONTO, Sept. 26, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has amended its non-exclusive investment agreement with Alumina Partners, LLC, a New York-based private investment partnership, providing the availability of up to CAD $30 million (previously CAD $20 million) over a 24-month period, to take advantage of new opportunities, increase operating flexibility, and strengthen the Company's balance sheet.
Sep 26, 2018 08:41 am ET
Beleave Announces Increased Investment Agreement with Alumina Partners and Executive Management Update
TORONTO, Sept. 26, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has amended its non-exclusive investment agreement with Alumina Partners, LLC, a New York-based private investment partnership, providing the availability of up to CAD $30 million (previously CAD $20 million) over a 24-month period, to take advantage of new opportunities, increase operating flexibility, and strengthen the Company's balance sheet.
Sep 20, 2018 01:35 pm ET
Investor Ideas Potcast, Cannabis News and Stocks on the Move: Canopy Growth Corporation, Canopy Rivers Inc. (TSXV: RIV), Organigram Holdings, CannaRoyalty and Beleave Inc.
Investor Ideas (https://www.investorideas.com), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca releases today’s edition of its series, Investorideas.com potcastsCM; cannabis...
Sep 20, 2018 09:18 am ET
Beleave Announces 867,000 Square Feet of New Indoor Growing Capacity in B.C.
TORONTO, Sept. 20, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce that is has entered into a partnership with Kannavis Biotech Corp. ("Kannavis") to invest, build and operate 867,000 square feet of indoor growing space in British Columbia in preparation for the anticipated demand for cannabis in the Canadian and International marketplace.
Sep 20, 2018 09:18 am ET
Beleave Announces 867,000 Square Feet of New Indoor Growing Capacity in B.C.
TORONTO, Sept. 20, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce that is has entered into a partnership with Kannavis Biotech Corp. ("Kannavis") to invest, build and operate 867,000 square feet of indoor growing space in British Columbia in preparation for the anticipated demand for cannabis in the Canadian and International marketplace.
Sep 14, 2018 05:09 pm ET
Beleave Announces Investment Agreement for up to $20 Million with Alumina Partners
TORONTO, Sept. 14, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has entered into a non-exclusive investment agreement with Alumina Partners, LLC, a New York-based private investment partnership, providing the availability of up to CAD $20 million over a 24-month period, to take advantage of new opportunities, increase operating flexibility, and strengthen the Company's balance sheet. The terms of the agreement will allow Beleave to draw down capital at will, on an as-needed basis, in a series of equity private placements of a minim
Sep 14, 2018 05:09 pm ET
Beleave Announces Investment Agreement for up to $20 Million with Alumina Partners
TORONTO, Sept. 14, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has entered into a non-exclusive investment agreement with Alumina Partners, LLC, a New York-based private investment partnership, providing the availability of up to CAD $20 million over a 24-month period, to take advantage of new opportunities, increase operating flexibility, and strengthen the Company's balance sheet. The terms of the agreement will allow Beleave to draw down capital at will, on an as-needed basis, in a series of equity private placements of
Sep 06, 2018 05:00 pm ET
Beleave Signs Agreement to Acquire 250,000 Square Feet of Greenhouse Space and 85 Acres of Land to Expand its Production Capabilities
TORONTO, Sept. 6, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has finalized plans to acquire 250,000 square feet of greenhouse space and 85 acres of land in London, Ontario to cultivate and harvest cannabis for distribution and sale in Canada.
Sep 06, 2018 05:00 pm ET
Beleave Signs Agreement to Acquire 250,000 Square Feet of Greenhouse Space and 85 Acres of Land to Expand its Production Capabilities
TORONTO, Sept. 6, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has finalized plans to acquire 250,000 square feet of greenhouse space and 85 acres of land in London, Ontario to cultivate and harvest cannabis for distribution and sale in Canada.
Aug 30, 2018 05:00 pm ET
Beleave Secures Prime Location for its First Saskatchewan Retail Store
TORONTO, Aug. 30, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce that it has secured a prime location for its first Saskatchewan retail store in the city of Lloydminster.
Aug 30, 2018 05:00 pm ET
Beleave Secures Prime Location for its First Saskatchewan Retail Store
TORONTO, Aug. 30, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce that it has secured a prime location for its first Saskatchewan retail store in the city of Lloydminster.
Aug 29, 2018 07:00 am ET
Beleave Receives First Purchase Order from BC Liquor Distribution Branch
TORONTO, Aug. 29, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is proud to announce that it has received its first purchase order from the BC Liquor Distribution Branch ("BCLDB"). The Company was selected by the BCLDB as an official supplier earlier last month following a comprehensive approval process.
Aug 29, 2018 07:00 am ET
Beleave Receives First Purchase Order from BC Liquor Distribution Branch
TORONTO, Aug. 29, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is proud to announce that it has received its first purchase order from the BC Liquor Distribution Branch ("BCLDB"). The Company was selected by the BCLDB as an official supplier earlier last month following a comprehensive approval process.
Aug 24, 2018 05:50 pm ET
Beleave Receives Purchase Order from Ontario Cannabis Store
TORONTO, Aug. 24, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is proud to announce that it has received its first purchase order from the Ontario Cannabis Store ("OCS"). This makes it one of the very first suppliers to support the sale of recreational cannabis in the province of Ontario.
Aug 24, 2018 05:50 pm ET
Beleave Receives Purchase Order from Ontario Cannabis Store
TORONTO, Aug. 24, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is proud to announce that it has received its first purchase order from the Ontario Cannabis Store ("OCS"). This makes it one of the very first suppliers to support the sale of recreational cannabis in the province of Ontario.
Aug 21, 2018 07:00 am ET
OCS Selects Beleave's Initial Line of Cannabis Products for Sale in Ontario
TORONTO, Aug. 21, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is proud to announce that it has been selected by the Ontario Cannabis Store ("OCS") for sale of its Seven Oaks brand and will be available for recreational sale after October 17, 2018.
Aug 21, 2018 07:00 am ET
OCS Selects Beleave's Initial Line of Cannabis Products for Sale in Ontario
TORONTO, Aug. 21, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is proud to announce that it has been selected by the Ontario Cannabis Store ("OCS") for sale of its Seven Oaks brand and will be available for recreational sale after October 17, 2018.
Aug 07, 2018 09:17 am ET
Beleave Expands Medi-Green Network with the Announcement of Two New Stores
TORONTO, Aug. 7, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce the opening of two new Medi-Green stores which will be located in London, Ontario and Montreal, Quebec.
Aug 07, 2018 09:17 am ET
Beleave Expands Medi-Green Network with the Announcement of Two New Stores
TORONTO, Aug. 7, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce the opening of two new Medi-Green stores which will be located in London, Ontario and Montreal, Quebec.
Jul 19, 2018 07:30 am ET
Beleave Rapidly Accelerates its Recreational Distribution Strategy by Acquiring Seven Oaks
TORONTO, July 19, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce the acquisition of 100% of the outstanding shares of Seven Oaks Inc. ("Seven Oaks") in an all share deal valued at $3,000,000.
Jul 19, 2018 07:30 am ET
Beleave Rapidly Accelerates its Recreational Distribution Strategy by Acquiring Seven Oaks
TORONTO, July 19, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is excited to announce the acquisition of 100% of the outstanding shares of Seven Oaks Inc. ("Seven Oaks") in an all share deal valued at $3,000,000.
Jul 05, 2018 08:28 am ET
Beleave Subsidiary Reaches Agreement to Lease 27 Hectares of Land in Colombia
TORONTO, July 5, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") today announced that its Colombian subsidiary, Procannmed S.A.S. ("Procannmed") has reached a land-lease agreement that will allow for the development and expansion of Procannmed's cultivation of cannabis for sale and extraction purposes.
Jul 05, 2018 08:28 am ET
Beleave Subsidiary Reaches Agreement to Lease 27 Hectares of Land in Colombia
TORONTO, July 5, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") today announced that its Colombian subsidiary, Procannmed S.A.S. ("Procannmed") has reached a land-lease agreement that will allow for the development and expansion of Procannmed's cultivation of cannabis for sale and extraction purposes.
Jun 29, 2018 10:25 am ET
MBLL Selects Seven Oaks Cannabis Products for Sale in Manitoba
WINNIPEG, June 29, 2018 /CNW/ - Seven Oaks is excited to announce that its brand will be available in Manitoba through Beleave Kannabis Corp. who has been selected by the Manitoba Liquor and Lotteries Corporation (MBLL) to supply cannabis to Manitoba retailers making Seven Oaks one of the first cannabis brands available to consumers upon legalization. The brand is strongly rooted in Manitoba with its founders being proud Metis from Winnipeg and the name itself being a reference to a historical Metis battle site.
Jun 22, 2018 08:12 am ET
Beleave Applauds Canadian Leadership and Continued Progress of Cannabis Legalization
TORONTO, June 22, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") would like to commend the outstanding leadership, tenacity, and bravery of the Canadian government in passing Bill C-45 into law. As the first G7 country to legalize cannabis, this forever reaffirms Canada's reputation as a forward-thinking nation to live and do business in.
Jun 22, 2018 08:12 am ET
Beleave Applauds Canadian Leadership and Continued Progress of Cannabis Legalization
TORONTO, June 22, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") would like to commend the outstanding leadership, tenacity, and bravery of the Canadian government in passing Bill C-45 into law. As the first G7 country to legalize cannabis, this forever reaffirms Canada's reputation as a forward-thinking nation to live and do business in.
Jun 21, 2018 08:44 am ET
Beleave Expands its Global Footprint into Colombia
TORONTO, June 21, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has acquired 51% of Procannmed S.A.S. ("Procannmed"), a privately held company that is fully licensed for the cultivation, production, extraction and distribution of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis in Colombia. The other 49% ownership was retained by the Colombian based operator ITRUST HOLDINGS S.A.S ("ITRUST"). These licenses enable the propagation of the full range of cannabis varieties and further enable Procannmed to develop a
Jun 21, 2018 08:44 am ET
Beleave Expands its Global Footprint into Colombia
TORONTO, June 21, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce it has acquired 51% of Procannmed S.A.S. ("Procannmed"), a privately held company that is fully licensed for the cultivation, production, extraction and distribution of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis in Colombia. The other 49% ownership was retained by the Colombian based operator ITRUST HOLDINGS S.A.S ("ITRUST"). These licenses enable the propagation of the full range of cannabis varieties and further enable Procannmed to dev
Jun 11, 2018 08:35 am ET
Beleave Inc. Announces Closing of First Tranche of Non-Brokered Private Placement of Units
TORONTO, June 11, 2018 /CNW/ - Beleave Inc. (CSE:  BE) (OTCQX:  BLEVF) ("Beleave" or the "Company") is pleased to announce that it has closed a first tranche of the Company's previously announced non-brokered private placement (the "Non-Brokered Offering") (See press release dated June 8, 2018).  In conjunction with this first closing, 2,500,000 units of the Company were issued at a price of $2.00 per unit for gross proceeds of $5 million. The Company may, at its discretion, increase the size of the Non-Brokered Offering.
Jun 11, 2018 08:35 am ET
Beleave Inc. Announces Closing of First Tranche of Non-Brokered Private Placement of Units
TORONTO, June 11, 2018 /PRNewswire/ - Beleave Inc. (CSE:  BE) (OTCQX:  BLEVF) ("Beleave" or the "Company") is pleased to announce that it has closed a first tranche of the Company's previously announced non-brokered private placement (the "Non-Brokered Offering") (See press release dated June 8, 2018).  In conjunction with this first closing, 2,500,000 units of the Company were issued at a price of $2.00 per unit for gross proceeds of $5 million. The Company may, at its discretion, increase the size of the Non-Brokered Offering.
Jun 08, 2018 06:09 pm ET
Beleave Inc. Announces $5 Million Non-Brokered Private Placement of Units
TORONTO, June 8, 2018 /CNW/ - Beleave Inc. (CSE: BE; OTCQX: BLEVF) ("Beleave" or the "Company"), a diversified biotech company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario and patient services clinics operating across Ontario under the Medi-Green brand, is pleased to announce its intention to complete a non-brokered private placement (the "Non-Brokered Offering") of up to 2,500,000 units of the Company at a price of $2.00 per unit for gross proceeds of approximately $5 million. The Company has already received sufficient interest from individuals to complete t
Jun 08, 2018 06:09 pm ET
Beleave Inc. Announces $5 Million Non-Brokered Private Placement of Units
TORONTO, June 8, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE; OTCQX: BLEVF) ("Beleave" or the "Company"), a diversified biotech company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario and patient services clinics operating across Ontario under the Medi-Green brand, is pleased to announce its intention to complete a non-brokered private placement (the "Non-Brokered Offering") of up to 2,500,000 units of the Company at a price of $2.00 per unit for gross proceeds of approximately $5 million. The Company has already received sufficient interest from individuals to com
Jun 04, 2018 08:18 am ET
Beleave Inc. Announces Successful Selection to Operate a Cannabis Retail Store in Saskatchewan
TORONTO, June 4, 2018 /CNW/ - Beleave Inc. (CSE:  BE; OTCQX:  BLEVF) ("Beleave" or the "Company"), a diversified biotech company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario and patient services clinics operating across Ontario under the Medi-Green brand, is pleased to announce that the Company has been selected to operate one of Saskatchewan's upcoming cannabis retail stores.
Jun 04, 2018 08:18 am ET
Beleave Inc. Announces Successful Selection to Operate a Cannabis Retail Store in Saskatchewan
TORONTO, June 4, 2018 /PRNewswire/ - Beleave Inc. (CSE:  BE; OTCQX:  BLEVF) ("Beleave" or the "Company"), a diversified biotech company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario and patient services clinics operating across Ontario under the Medi-Green brand, is pleased to announce that the Company has been selected to operate one of Saskatchewan's upcoming cannabis retail stores.
May 22, 2018 08:20 am ET
Beleave Expands Medi-Green Cannabis Clinic Network with Additional Location in London, Ontario
TORONTO, May 22, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that it had added another location to its network of Medical Cannabis Clinics. The new location is located at 211 Dundas Street in London, Ontario and is expected to open shortly.
May 22, 2018 08:20 am ET
Beleave Expands Medi-Green Cannabis Clinic Network with Additional Location in London, Ontario
TORONTO, May 22, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that it had added another location to its network of Medical Cannabis Clinics. The new location is located at 211 Dundas Street in London, Ontario and is expected to open shortly.
May 17, 2018 08:05 am ET
/R E P E A T -- Beleave Provides Guidance on Veterans Affairs Canada Coverage/
TORONTO, May 16, 2018 /CNW/ - Beleave Inc. (CSE:  BE; OTCQX:  BLEVF) ("Beleave" or the "Company") due to an influx of inquiries from patients would like to provide guidance on the previously released Veterans Affairs Canada's Medical Cannabis Program administered by Medavie Blue Cross. 
May 17, 2018 08:05 am ET
/R E P E A T -- Beleave Provides Guidance on Veterans Affairs Canada Coverage/
TORONTO, May 16, 2018 /PRNewswire/ - Beleave Inc. (CSE:  BE; OTCQX:  BLEVF) ("Beleave" or the "Company") due to an influx of inquiries from patients would like to provide guidance on the previously released Veterans Affairs Canada's Medical Cannabis Program administered by Medavie Blue Cross. 
May 16, 2018 05:43 pm ET
Beleave Provides Guidance on Veterans Affairs Canada Coverage
TORONTO, May 16, 2018 /CNW/ - Beleave Inc. (CSE:  BE; OTCQX:  BLEVF) ("Beleave" or the "Company") due to an influx of inquiries from patients would like to provide guidance on the previously released Veterans Affairs Canada's Medical Cannabis Program administered by Medavie Blue Cross. 
May 16, 2018 05:43 pm ET
Beleave Provides Guidance on Veterans Affairs Canada Coverage
TORONTO, May 16, 2018 /PRNewswire/ - Beleave Inc. (CSE:  BE; OTCQX:  BLEVF) ("Beleave" or the "Company") due to an influx of inquiries from patients would like to provide guidance on the previously released Veterans Affairs Canada's Medical Cannabis Program administered by Medavie Blue Cross. 
May 16, 2018 07:35 am ET
Beleave Approved to Provide Medical Cannabis to Patients with Qualified Insurance Coverage from Medavie Blue Cross
TORONTO, May 16, 2018 /CNW/ - Beleave Inc. (CSE: BE; OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly owned subsidiary Beleave Kannabis Corp. has received its approval and provider number to service those who have qualified for cannabis coverage through Medavie Blue Cross including the Canadian veteran community.  With over 1,000,000 card holders Medavie Blue Cross is one of Canada's leading Blue Cross plans and although each card holder's benefits may differ, cannabis coverage is available to patients approved by Blue Cross.
May 16, 2018 07:35 am ET
Beleave Approved to Provide Medical Cannabis to Patients with Qualified Insurance Coverage from Medavie Blue Cross
TORONTO, May 16, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE; OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly owned subsidiary Beleave Kannabis Corp. has received its approval and provider number to service those who have qualified for cannabis coverage through Medavie Blue Cross including the Canadian veteran community.  With over 1,000,000 card holders Medavie Blue Cross is one of Canada's leading Blue Cross plans and although each card holder's benefits may differ, cannabis coverage is available to patients approved by Blue Cross.
May 15, 2018 08:56 am ET
Beleave Launches Robust Shareholder Communications Initiative
TORONTO, May 15, 2018 /CNW/ - Beleave Inc. (CSE:  BE; OTCQX:  BLEVF) ("Beleave" or the "Company"), a diversified biotech company with a purpose-built ACMPR licensed cannabis facility in Hamilton, Ontario and patient services clinics operating across Ontario under the Medi-Green brand, today announced the launch of an expanded shareholder communications initiative designed to provide improved visibility into Beleave's current and planned operations.  The initiative was prompted by an increase in shareholder inquiries, the Company's desire for increased transparency for its stakeholders and th
May 15, 2018 08:56 am ET
Beleave Launches Robust Shareholder Communications Initiative
TORONTO, May 15, 2018 /PRNewswire/ - Beleave Inc. (CSE:  BE; OTCQX:  BLEVF) ("Beleave" or the "Company"), a diversified biotech company with a purpose-built ACMPR licensed cannabis facility in Hamilton, Ontario and patient services clinics operating across Ontario under the Medi-Green brand, today announced the launch of an expanded shareholder communications initiative designed to provide improved visibility into Beleave's current and planned operations.  The initiative was prompted by an increase in shareholder inquiries, the Company's desire for increased transparency for its stakeholders
May 10, 2018 05:38 pm ET
Beleave Closes Acquisition of Medi-Green Cannabis Clinic Network
TORONTO, May 10, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that it has closed on its previously announced transaction (see press release dated May 1, 2018) to purchase all of the outstanding shares of 9334416 Canada Inc., o/a Medi-Green, Karmacann, and My-Grow ("Medi-Green"), a leading network of medical cannabis clinics with three current locations across Ontario (the "Transaction").
May 10, 2018 05:38 pm ET
Beleave Closes Acquisition of Medi-Green Cannabis Clinic Network
TORONTO, May 10, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that it has closed on its previously announced transaction (see press release dated May 1, 2018) to purchase all of the outstanding shares of 9334416 Canada Inc., o/a Medi-Green, Karmacann, and My-Grow ("Medi-Green"), a leading network of medical cannabis clinics with three current locations across Ontario (the "Transaction").
May 10, 2018 07:35 am ET
Beleave Begins Extraction at Newly Commissioned State-of-the-Art Industrial Extraction Laboratory
TORONTO, May 10, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) (OTCQX: BLEVF) is pleased to announce that it has completed the construction and commissioning of a new state-of-the-art industrial extraction laboratory at its production facility located in Hamilton, Ontario. The laboratory design is based on recent work stemming from research collaborations with principal investigators at Ryerson University, Department of Chemistry and Biology, and which has led to the development of a proprietary and large-scale industrial method for the extraction and purification of canna
May 10, 2018 07:35 am ET
Beleave Begins Extraction at Newly Commissioned State-of-the-Art Industrial Extraction Laboratory
TORONTO, May 10, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) (OTCQX: BLEVF) is pleased to announce that it has completed the construction and commissioning of a new state-of-the-art industrial extraction laboratory at its production facility located in Hamilton, Ontario. The laboratory design is based on recent work stemming from research collaborations with principal investigators at Ryerson University, Department of Chemistry and Biology, and which has led to the development of a proprietary and large-scale industrial method for the extraction and purification o
May 03, 2018 06:16 pm ET
Beleave Provides Baseline Medical Cannabis Yield Projections
TORONTO, May 3, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce initial projections for the sale of medical cannabis. The Company is currently operating out of its 14,500 sq. ft. facility in Hamilton, ON with its additional 80,000 sq. ft. greenhouse expansion well underway and expected to come online by the beginning of the third quarter.
May 02, 2018 09:10 am ET
Beleave Inc. Acquires Network of Medical Cannabis Clinics in Ontario - Video Available on InvestmentPitch.com
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2018) - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) is acquiring 100% of the outstanding shares of 9334416 Canada Inc., which operates as Medi-Green, Karmacann, and My-Grow, a network of medical cannabis clinics with 3 locations across Ontario.
May 01, 2018 10:56 am ET
IIROC Trade Resumption - BE
VANCOUVER, May 1, 2018 /CNW/ - Trading resumes in:
May 01, 2018 10:48 am ET
Beleave to Acquire Medi-Green Cannabis Clinic Network
TORONTO, May 1, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that it has entered into a definitive agreement to purchase all of the outstanding shares of 9334416 Canada Inc., o/a Medi-Green, Karmacann, and My-Grow ("Medi-Green"), a leading network of medical cannabis clinics with three current locations across Ontario (the "Transaction"). Subject to customary closing conditions, including the completion of certain filings with the Canadian Securities Exchange (the "CSE"), the Transaction is expected to close on or about May 8, 2018 (th
May 01, 2018 10:48 am ET
Beleave to Acquire Medi-Green Cannabis Clinic Network
TORONTO, May 1, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that it has entered into a definitive agreement to purchase all of the outstanding shares of 9334416 Canada Inc., o/a Medi-Green, Karmacann, and My-Grow ("Medi-Green"), a leading network of medical cannabis clinics with three current locations across Ontario (the "Transaction"). Subject to customary closing conditions, including the completion of certain filings with the Canadian Securities Exchange (the "CSE"), the Transaction is expected to close on or about May 8, 2
May 01, 2018 09:36 am ET
IIROC Trading Halt - BE
VANCOUVER, May 1, 2018 /CNW/ - The following issues have been halted by IIROC:
Apr 26, 2018 04:37 pm ET
Beleave Closes $5,000,000 Non-Brokered Private Placement of Units
TORONTO, April 26, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce the closing today its previously announced non-brokered private placement (the "Non-Brokered Offering") for gross proceeds of approximately $5,000,000.  Pursuant to the Non-Brokered Offering the Company issued an aggregate of 2,857,143 units of the Company at a price of $1.75 per unit.
Apr 26, 2018 04:37 pm ET
Beleave Closes $5,000,000 Non-Brokered Private Placement of Units
TORONTO, April 26, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce the closing today its previously announced non-brokered private placement (the "Non-Brokered Offering") for gross proceeds of approximately $5,000,000.  Pursuant to the Non-Brokered Offering the Company issued an aggregate of 2,857,143 units of the Company at a price of $1.75 per unit.
Apr 25, 2018 08:05 am ET
Beleave Confirms Receipt of Commitments to Fulfill $5,000,000 Private Placement
TORONTO, April 25, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) in reference to its previously announced Non-Brokered Private Placement dated April 24, 2018, (the "Non-Brokered Offering") is pleased to announce that it has received binding commitments for total proceeds of $5,000,000 at a price of $1.75 per unit.  Subject to customary closing conditions, including CSE approval, the Non-Brokered Offering is now expected to close on or about April 26, 2018.
Apr 25, 2018 08:05 am ET
Beleave Confirms Receipt of Commitments to Fulfill $5,000,000 Private Placement
TORONTO, April 25, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) in reference to its previously announced Non-Brokered Private Placement dated April 24, 2018, (the "Non-Brokered Offering") is pleased to announce that it has received binding commitments for total proceeds of $5,000,000 at a price of $1.75 per unit.  Subject to customary closing conditions, including CSE approval, the Non-Brokered Offering is now expected to close on or about April 26, 2018.
Apr 24, 2018 08:41 pm ET
Beleave Announces $5 Million Non-Brokered Private Placement of Units
TORONTO, April 24, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce its intention to complete a non-brokered private placement (the "Non-Brokered Offering") of up to 2,857,143 units of the Company at a price of $1.75 per unit for gross proceeds of approximately $5 million. The Company may, at its sole discretion, increase the size of the Non-Brokered Offering.
Apr 24, 2018 08:41 pm ET
Beleave Announces $5 Million Non-Brokered Private Placement of Units
TORONTO, April 24, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce its intention to complete a non-brokered private placement (the "Non-Brokered Offering") of up to 2,857,143 units of the Company at a price of $1.75 per unit for gross proceeds of approximately $5 million. The Company may, at its sole discretion, increase the size of the Non-Brokered Offering.
Apr 16, 2018 09:22 am ET
/R E P E A T -- Beleave Receives Sales License from Health Canada/
TORONTO, April 13, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corp., has received its sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (the "ACMPR").
Apr 16, 2018 09:22 am ET
/R E P E A T -- Beleave Receives Sales License from Health Canada/
TORONTO, April 13, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corp., has received its sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (the "ACMPR").
Apr 13, 2018 05:01 pm ET
Beleave Receives Sales License from Health Canada
TORONTO, April 13, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corp., has received its sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (the "ACMPR").
Apr 13, 2018 05:01 pm ET
Beleave Receives Sales License from Health Canada
TORONTO, April 13, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corp., has received its sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (the "ACMPR").
Mar 23, 2018 01:54 pm ET
Beleave - Everything You've Ever Wanted to Know
TORONTO, March 23, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to, on the back of yesterdays positive Senate vote in favour of Bill C-45, provide a video overview of each of the company's current initiatives. 
Mar 23, 2018 01:54 pm ET
Beleave - Everything You've Ever Wanted to Know
TORONTO, March 23, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to, on the back of yesterdays positive Senate vote in favour of Bill C-45, provide a video overview of each of the company's current initiatives. 
Mar 19, 2018 02:00 pm ET
Horizons ETFs Completes Rebalance of its Marijuana Life Sciences Index ETF
HMMJ adds 10 new stocks as part of this latest quarterly rebalancing
Mar 07, 2018 07:30 am ET
Beleave Announces Significant Appointments to its Board of Directors
TORONTO, March 7, 2018 /CNW/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce the appointment of Mark Heselton and Mark Miles to the Company's Board of Directors.
Mar 07, 2018 07:30 am ET
Beleave Announces Significant Appointments to its Board of Directors
TORONTO, March 7, 2018 /PRNewswire/ - Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce the appointment of Mark Heselton and Mark Miles to the Company's Board of Directors.
Mar 01, 2018 04:30 pm ET
Beleave Provides Update on Manitoba Retail Licensing Agreement
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE); (OTCQX:BLEVF) would like to provide an update with regard to recent retail licensing grants in the province of Manitoba.  On January 3rd, 2018 the...
Jan 31, 2018 07:35 am ET
Beleave Receives Notification of Pre-Sale Inspection Date
TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE)(OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that the Company's pre-sale inspection has been scheduled for February 8, 2018....
Jan 04, 2018 07:34 am ET
Beleave Announces Issuance of Options
Beleave Inc. ("Beleave" or the "Company") (CSE:BE)(CSE:BE.CN)(CSNX:BE)(OTCQX:BLEVF) announces that it has granted 1,350,000 stock options to purchase common shares (the "Options") to the directors and management team members of Beleave in accordance...
Jan 04, 2018 07:34 am ET
Beleave Announces Issuance of Options
Beleave Inc. ("Beleave" or the "Company") (CSE: BE)(CSE: BE.CN)(CSNX: BE)(OTCQX: BLEVF) announces that it has granted 1,350,000 stock options to purchase common shares (the "Options") to the directors and management team members of Beleave in accordance with the Company's stock option plan. Each option is exercisable to purchase one common share of the Company at $3.00 per common share. All Options vest immediately and have a five-year term.
Jan 03, 2018 07:25 am ET
Beleave Signs Letter of Intent with Seven Oaks Cannabis
TORONTO, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has signed a letter of intent with Seven Oaks Cannabis Inc. (“Seven Oaks”) for Seven Oaks to...
Dec 15, 2017 07:33 am ET
IIROC Trade Resumption - BE
VANCOUVER, Dec. 15, 2017 /CNW/ - Trading resumes in:
Dec 14, 2017 08:07 pm ET
Beleave Provides Business Update
TORONTO, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that, upon the Company's confirmation that the Company's production, testing, manufacturing,...
Dec 14, 2017 02:49 pm ET
IIROC Trading Halt - BE
VANCOUVER, Dec. 14, 2017 /CNW/ - The following issues have been halted by IIROC:
Dec 07, 2017 07:45 am ET
Beleave Signs Brand Licensing Agreement with Kevin Smith & Jason Mewes
TORONTO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has entered into a Brand Licensing Agreement with Kevin Smith and Jason Mewes, better known as their onscreen...
Dec 05, 2017 06:37 pm ET
Beleave Closes $9.95 Million Non-Brokered Private Placement of Units
TORONTO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce the completion of a non-brokered private placement (the "Non-Brokered Offering") of units of the Company at a price of...
Dec 04, 2017 06:18 pm ET
Beleave Receives License to Produce Cannabis Oils from Health Canada
TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE)( OTCQX:BLEVF) is pleased to announce it has been granted a license by Health Canada to begin commercial production of cannabis oils. 
Nov 30, 2017 07:52 pm ET
Beleave Announces Upsize of Previously Announced Non-Brokered Private Placement
Beleave Inc. ("Beleave" or the "Company") (CSE:BE)(CSE:BE.CN)(CSNX:BE)(OTCQX:BLEVF) is pleased to announce that due to substantial interest, the Company has increased the size of its previously announced non-brokered private placement to offer...
Nov 30, 2017 07:52 pm ET
Beleave Announces Upsize of Previously Announced Non-Brokered Private Placement
Beleave Inc. ("Beleave" or the "Company") (CSE: BE)(CSE: BE.CN)(CSNX: BE)(OTCQX: BLEVF) is pleased to announce that due to substantial interest, the Company has increased the size of its previously announced non-brokered private placement to offer up to 6,666,667 units of the Company for maximum gross proceeds of approximately $10 million (the "Non-Brokered Offering").
Nov 29, 2017 07:30 pm ET
Beleave Aims to Raise Awareness by Supporting Don't Drive High Campaign
Beleave Inc. ("Beleave" or the "Company") (CSE:BE)(CSE:BE.CN)(CSNX:BE)(OTCQX:BLEVF) is pleased to support initiatives like the "Don't Drive High" campaign that make the public aware of the potential repercussions to driving under the influence. As...
Nov 29, 2017 07:30 pm ET
Beleave Aims to Raise Awareness by Supporting Don't Drive High Campaign
Beleave Inc. ("Beleave" or the "Company") (CSE: BE)(CSE: BE.CN)(CSNX: BE)(OTCQX: BLEVF) is pleased to support initiatives like the "Don't Drive High" campaign that make the public aware of the potential repercussions to driving under the influence. As we get closer to the legalization of recreational cannabis in Canada in July 2018, Ontario is planning on introducing tougher penalties for drivers caught under the influence.
Nov 20, 2017 07:25 am ET
Beleave Announces $5 Million Non-Brokered Private Placement of Units
TORONTO, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce its intention to complete a non-brokered private placement (the "Non-Brokered Offering") of up to 3,333,334 units of the Company at...
Nov 10, 2017 07:30 am ET
Beleave Supports Recent Council Decision and Continues Expansion Uninterrupted
TORONTO, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (“Beleave”) (CSE:BE) (OTCQX:BLEVF) strongly supports The City of Hamilton council’s decision to turn down the motion for any new restrictions pertaining to the land use planning framework for the...
Oct 24, 2017 07:30 am ET
Beleave and Dr. Michael Rogers Begin Research in Cannabis Food and Drug Delivery
TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (“Beleave”) (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it will begin a research program with Dr. Michael Rogers to develop and characterize the bioavailability of novel cannabinoid food and drug delivery systems for oral administration using lipid-based nano-systems. Dr. Rogers is an Associate Professor in the Department of Food Sciences at the University of Guelph, and the holder of a Canada Research Chair in Food Nanotechnology....
Oct 17, 2017 07:30 am ET
REPEAT - Cannabis Wheaton Provides Initial Advance of $5,000,000 to Beleave
Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) ("Cannabis Wheaton"or"CBW") and Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") are pleased to announce that, further to the news release dated October 5, 2017, CBW has provided an...
Oct 17, 2017 12:01 am ET
Cannabis Wheaton Provides Initial Advance of $5,000,000 to Beleave
Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) ("Cannabis Wheaton"or"CBW") and Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") are pleased to announce that, further to the news release dated October 5, 2017, CBW has provided an...
Oct 10, 2017 02:43 pm ET
Beleave Appoints New Chief Executive Officer Andrew Wnek
TORONTO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce the appointment of its new Chief Executive Officer, Andrew Wnek as Dr. Roger Ferreira moves into the role of Chief Science Officer....
Sep 28, 2017 08:00 am ET
Beleave Completes First Harvest at Hamilton Facility
TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has completed harvesting and drying its first two lots of cannabis at its Hamilton, Ontario facility; a process required by Health Canada prior to requesting a sales license. The Company will apply for a license to sell dried cannabis after it has received confirmation from a third-party laboratory that quality assurance testing results are compliant with the Access to Cannabis for Medical Purposes Regulations....